Viruria in Dogs after
Viruria has been demonstrated in many human and animal viral infections (1, 2) . Preliminary studies in mice and rats by Schultz and Neva (3) established that virus passes from blood to urine within 30 minutes after intravenous injection under the conditions of their experiments. This viruria was referred to as "immediate viruria" and was considered to be distinct from the viruria that occurs during acute infections. In the present study, dogs were used in experiments that were technically too difficult to be carried out in smaller laboratory animals. Renal physiological and virological techniques were combined to study the mechanisms of virus clearance from the blood by the kidney and to establish the locus in the nephron where virus gains entry into the urine. Previous studies of a similar nature include those of Keller and Zatzman (4) , who injected Bacillus megatheriumi phage and studied its renal excretion and distribution in the liver and spleen of dogs. Petrov (5) used injection of bacteriophage of Escherichia coli in dogs to establish clearance values for these virus particles. Although Schultz and Neva (3) were unable to determine the renal contribution to viruria in rats, they observed that the rat bladder is permeable to small numbers of virus particles.
Our present studies demonstrate that Coxsackie B-1 virus (a small enterovirus) can pass rapidly from blood to the urine after injection into a renal artery. Similar findings were noted after injection of virus into the aorta or into a peripheral vein.
Moreover, with the stop-flow technique (6) , lo- calization of the point of initial viruria was possible. The site appears to be in a distal portion of the nephron, perhaps in the distal tubule.
Methods

Experimental design
Male mongrel dogs weighing at least 17 kg were anesthetized with 10 to 15 mg per kg of sodium pentothal injected intravenously. A no. 18 Rochester catheter (2 inches in length) was inserted into the right renal artery by a modification of the technique of Pullman, Lavender, Aho, and Rasmussen (7) . The catheter within the right renal artery was attached to a constant infusion pump, and a 0.9% NaCl' solution containing 0.01 mg per ml heparin sodium was infused at 1.23 ml per minute.
Through an abdominal incision, no. 240 polyethylene catheters (i.d., 0.066 inch; o.d., 0.095 inch) were placed in the upper portions of both ureters. After 60-to 90-minute intervals, urine specimens were examined for microscopic hematuria (more than a rare erythrocyte per high power field in a centrifuged specimen) before control periods were collected. The experiments to be reported were selected from an original total of 23 dogs. Reasons for discarding the experimental results from the other animals included gross hematuria (four animals), microscopic hematuria (two animals), questionable renal arterial catheter placement (two animals), and postmortem evidence of severe diffuse renal disease without hematuria (one animal). An infusion of 15% mannitol into a cephalic vein usually was given to insure good urine flow rates; in some of the stop-flow experiments this infusion rate was as high as 14 ml per minute.
The virus inoculum described below was first introduced into the tubing leading to the renal artery and then infused by increasing flow through the pump to 9 ml per minute. With heparin as anticoagulant, blood samples were drawn into sterile syringes from the right femoral artery. Two types of experiments were performed: a) those in which urine was allowed to flow freely from the ureteral catheters, and b) those in which the stop-flow technique was used.
1953
During the free-flow experiments, roughly equal urine flow was established on the two sides (Table I) . After control periods, virus. inoculum, containing approximately 1 gc Iodohippurate-'I (Hippuran-311) 1 was infused.
Urine collections were made directly into the sterile glassware to be employed in the quantitation of virus.
In the stop-flow experiments, 15% mannitol was infused until the urine flow rates were about 5 ml per minute from each side. Control clearance periods were collected. Both ureteral catheters were then clamped for 6 to 8 minutes. During the final 2 minutes of the clamping, virus inoculum containing Hippuran-1nI as a proximal tubular marker was injected into the renal artery. After release, the rapid flow of urine was collected into previously unused 2-ml glass vials placed in a metal rack on a track. Each sample contained approximately 1 ml of urine. Twenty to 30 vials were filled from each ureter within the collection period of 3 minutes. Immediately after the stop-flow collections, conventional renal clearance period collections were made again. In four experiments, sodium ferrocyanide, 1 g in 10 ml of normal saline, was injected into a cephalic vein at the same time that virus was being infused into the renal artery. This substance marked "glomerular" samples of the stop-flow collections (8) .
All animals were sacrificed at the termination of the experiment. Postmortem examinations, including en bloc removal of the aorta, renal arteries, and both kidneys, were made to confirm the position of the renal arterial catheter and to observe the gross appearance of kidneys and ureters. Sections of kidney were fixed in formalin, stained with hematoxylin and eosin, and examined by light microscopy.
Virus techniques
Tissue culture. A derivative of the Hep-2 cell line purified by single colony cloning was used throughout. 2 The cells were maintained in continuous passage in 32-ounce, flat prescription bottles as monolayer cultures and dispersed by trypsinization for passage or setting up tube or plaque bottles. Growth medium was modified Eagle's minimal essential medium in Hank's buffered saline solution containing nonessential amino acids 3 and supplemented with 10% inactivated calf serum. Cultures were maintained after inoculation into a medium with 5%o calf serum. Both growth and maintenance media contained penicillin G, 100 U per ml, and streptomycin, 100 ,ug per ml. The Hep cell line used for virus detection was known to be contaminated with pleuropneumonia-like organisms (PPLO), but subsequent parallel titrations in it and a line that was PPLO free gave identical results in both cell lines.
Virus. Coxsackie B-1 virus derived from the prototype Conn-5 strain of the American type culture collection 1Abbott Laboratories, North Chicago, Ill. was received after three cycles of plaque purification in Hep-2 cells. A single large pool was prepared by high multiplicity infection of bottle cultures of Hep-2 cells that were incubated for 24 hours in buffered saline solution. The infected cells were frozen and thawed twice, and the cell debris was removed by centrifugation at 2,500 rpm and 40 C for 15 minutes. The clarified virus suspension was dispensed into 3-ounce bottles and stored at -200 C until used. The virus titer of thawed samples remained at 108 TCID50 (50% tissue culture infective dose) per ml. Thus, the virus inoculum (8 to 10 ml), diluted if necessary in buffered saline solution, contained in addition to Coxsackie B-1 virus, the Na, K, and Mg salts of Hank's buffer, bicarbonate, penicillin, streptomycin, phenol red in a concentration of 0.4 g per ml, and unidentified soluble components of the virus infected cells. It was shown to be free of bacterial contamination by testing 1-ml samples with thioglycollate broth, blood agar, PPLO agar, and Sabaroud's medium. Virus was reisolated from urine on three occasions and identified by a standard typing procedure with Coxsackie B-1 rabbit antiserum. 4 Virus detection. 1) Tube method: Virus was detected in specimens of blood or urine by inoculating the cell cultures with 0.1 to 0.2 ml of material in appropriate dilution in phosphate buffered saline, pH 7.2. All tubes were placed in a roller drum at 350 ± 1°C and read for cytopathic effects of virus on days 3 and 7 when medium was changed. All tubes were discarded at 10 days after final reading. Only complete specific destruction of the cell sheet was considered a positive result. The end point of titrations for the TCID50 was estimated by the ReedMuench method using 4 tubes per log dilution implying a SD of + 0.3 to 0.47 log1o according to the empiric Pizzi formula (9). Tube cultures were particularly useful in detecting minute amounts of virus in urine.
2) Plaque method: In many experiments, the soft agar overlay method (10) for plaque titrations was also used to detect virus in parallel with tube titrations. Two-tenths ml of inoculum was absorbed to at least three plaque cultures in 3-ounce bottles for 1 hour before addition of the agar overlay. Plaque techniques were inadequate for detecting small amounts of virus and were not used in stop-flow experiments. All data will, therefore, be reported in terms of the TCID5o of the tube titrations used in each experiment.
Chemical and isotopic determinations
Exogenous creatinine clearance was measured according to standard techniques (11) . Plasma determined from urine collected after the stop-flow specimens, they were always of the order of magnitude of 10-3. This fact plus the virtual absence of microscopic hematuria in the same specimens suggest strongly that the viruria seen in stop-flow experiments cannot be accounted for by bleeding into tubular lumina. These experiments also indicate the rapidity with which virus may enter dog urine from blood, since the first specimens containing virus were collected less than 2.5 minutes after starting the injection.
Routine histologic studies of sections from kidneys obtained within 1 hour of completion of these experiments usually revealed minimal edema and slight round cell infiltration. Similar findings were noted in dogs used for renal physiological studies without the injection of virus. Occasionally, gross examination of the kidneys revealed a macroscopic parenchymal scar. In none of these instances did microscopic examination show diffuse renal disease.
Discussion
Coxsackie B-1 virus is well suited to studies of viruria, since it is stable and easily detected in biological fluids. Being approximately 30 mp in diameter and roughly spherical in shape (16) , it is representative of a large group of mammalian RNA enteroviruses, now called picornaviruses (17) . In addition, it is considerably larger than many of the macromolecules that have been studied in the urine of man and animals (18, 19) . This agent was also isolated from the urine of infected suckling mice in studies by Pappenheimer, Kunz, and Richardson in 1951 (20) . We used Coxsackie B-1 virus to determine whether macromolecules of the size of virus particles can pass from the circulating blood into the urine. In dogs, a dose of Coxsackie B-1 virus resulting in sustained viremia of more than 102 TCID50 per ml resulted in viruria. This occurred within minutes after direct renal arterial injection, but occurred bilaterally in most experiments, suggesting that transient very high blood levels on the injected side did not result in augmented virus excretion.
Evidently sustained exposure to high levels of circulating virus was necessary for viruria.
Stop-flow studies indicated that in most nephrons the virus entered urine in or just after the area corresponding to the dip in sodium concentration usually attributed to distal tubular function. This is consistent with the data first obtained in free-flow experiments in which virus always appeared in ureteral urine before or coincident with the detection of Hippuran-131I or phenol red. Schultz and Neva (3) recovered poliovirus from the bladder urine of a rat in which both ureters had been ligated before the intravenous injection of virus. From this experiment, it was considered that permeability to virus might be demonstrable in other parts of the collecting system of the genitourinary tract. This was not the case in our studies of Coxsackie B-1 viruria in dogs, however, since virus was found in the urine at the tubular level, but not from specimens in contact with the pelvis or short segment of ureter above the catheters. Unfortunately, our experimental design did not exclude passage of virus through parts of the nephron above the distal segment.
In three stop-flow experiments, however, virus was detected in specimens stopped in tubular areas, but not in those that were contained in the glomeruli during stop flow. This suggests that the tubular areas are more likely to allow passage of virus particles, but does not eliminate some passage across the glomerulus when viremia is intense.
How accurately do these data reflect physiological events and not experimental artifacts? The problem of direct blood contamination in collection of specimens was considered. We selected only the experiments in which rare erythrocytes (or none at all) were present in centrifuged specimens of urine collected before or after the experimental procedure. Since red cells were present in much higher concentrations in the plasma than virus particles, we felt that this was a sufficient precaution to eliminate "bleeding" (as we normally think of it) as a cause of viruria in our experiments. There are also other aspects of the study that are not readily controlled, such as anesthesia, stress of surgery, and diuresis, which may have affected the occurrence of viruria. The extent to which the quantitative data can be applied to the unanesthetized, intact animal remains to be determined. Passage of virus into urine was not shown to affect the physiological function studies of the nephron, nor were morphological changes attributable to viruria seen in routine histological studies.
Viruria occurs in virus infections of dogs with canine hepatitis (21) and distemper viruses (22) . Distemper antigens have been detected in bladder mucosa by fluorescent antibody techniques, suggesting this as a site for viral entry into urine (22 (4) .
Finally, these studies bear on the question of the origin of other macromolecules found in urine.
Sites of viral permeation presumably could be available to other molecules of smaller or equal size. Because viruses are capable of quantitation in very minute amounts (sensitive detection methods permit fewer than 10 infective particles to be identified in some systems), it would be expected that the processes governing their excretion could be more precisely identified. Studies with inert particles have been reported that also indicate renal permeability to large particles. Farquhar, Wissig, and Palade, in studies using the electron microscope (24) , showed the passage through the intact glomerulus of very few of many ferritin particles circulating in rat blood, but tubular passage was not studied. Ferritin is approximately 100 A in diameter, which would place it below the size of the smallest known viruses. Grotte (25) has postulated capillary "leaks" in the kidney through which large molecules may pass in "bulk flow," as estimated from his studies using dextran particles varying in molecular weight from 50,000 to 300,000. Swann, Ormsby, Delashaw, and Tharp have made similar suggestions (26) . Such studies do not detract from the general concept that the kidney is a selective and efficient filter. They do indicate, however, that the retention of certain particles is not perfect. These imperfections may have biological significance related to the nature of the particle and to certain disease processes. Certainly our studies suggest that further detailed microscopic examination of the proximal and distal tubular regions is indicated to explore the morphologic basis for their permeability to large molecules such as Coxsackie B-1 virus.
Summary
Injection of Coxsackie B-1 virus into the right renal artery of anesthetized dogs resulted in virus detection in the urine if viremia greater than 102 50% tissue culture infective dose per ml was sustained. Virus appeared in ureteral urine from both kidneys, despite unilateral injections, as early as 30 seconds after virus infusion for approximately 1 minute. In experiments with free flow of urine, virus was always detected before or coincident with the appearance of simultaneously injected Hippuran-131I or phenol red. In stop-flow studies, virus was first detected in specimens from the distal tubular area (or just proximal to it) as determined from sodium concentrations, but continued to appear in specimens from more proximal areas of the nephron. In three experiments virus was present in tubular urine but absent in glomerular urine marked by the excretion of ferrocyanide. We conclude that facilitated excretion of Coxsackie B-1 virus into urine in the area of the distal tubule occurred under the conditions of these experiments.
